ArticleScientific reports2023

Assessing the effectiveness of camrelizumab plus apatinib versus sorafenib for the treatment of primary liver cancer: a single-center retrospective study.

Dongbo Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.